CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE
4.1 Overview
4.1.1 Market size and forecast
4.2 imaging
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 laboratory tests
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 endoscopy
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 biopsy
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: LIVER DISEASE DIAGNOSTICS MARKET, BY END USE
5.1 Overview
5.1.1 Market size and forecast
5.2 hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 laboratories
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: LIVER DISEASE DIAGNOSTICS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Technique
6.2.3 North America Market size and forecast, by End Use
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Technique
6.2.4.1.2 Market size and forecast, by End Use
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Technique
6.2.4.2.2 Market size and forecast, by End Use
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Technique
6.2.4.3.2 Market size and forecast, by End Use
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Technique
6.3.3 Europe Market size and forecast, by End Use
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Technique
6.3.4.1.2 Market size and forecast, by End Use
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Technique
6.3.4.2.2 Market size and forecast, by End Use
6.3.4.3 UK
6.3.4.3.1 Market size and forecast, by Technique
6.3.4.3.2 Market size and forecast, by End Use
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Technique
6.3.4.4.2 Market size and forecast, by End Use
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Technique
6.3.4.5.2 Market size and forecast, by End Use
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Technique
6.3.4.6.2 Market size and forecast, by End Use
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Technique
6.4.3 Asia-Pacific Market size and forecast, by End Use
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Technique
6.4.4.1.2 Market size and forecast, by End Use
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Technique
6.4.4.2.2 Market size and forecast, by End Use
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Technique
6.4.4.3.2 Market size and forecast, by End Use
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Technique
6.4.4.4.2 Market size and forecast, by End Use
6.4.4.5 Australia
6.4.4.5.1 Market size and forecast, by Technique
6.4.4.5.2 Market size and forecast, by End Use
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Technique
6.4.4.6.2 Market size and forecast, by End Use
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Technique
6.5.3 LAMEA Market size and forecast, by End Use
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Technique
6.5.4.1.2 Market size and forecast, by End Use
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Technique
6.5.4.2.2 Market size and forecast, by End Use
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Technique
6.5.4.3.2 Market size and forecast, by End Use
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Technique
6.5.4.4.2 Market size and forecast, by End Use
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Bio-Rad Laboratories Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Cosara Diagnostics Pvt Ltd
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Echosens
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Meril Life Sciences Pvt. Ltd.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 PerkinElmer
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Qiagen N.V.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Siemen’s AG
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Thermo Fisher Scientific Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Trivitron Healthcare
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
